Loading clinical trials...
Loading clinical trials...
IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored.
IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Cologne
Cologne, Germany
Start Date
October 1, 2012
Primary Completion Date
December 1, 2014
Completion Date
June 1, 2016
Last Updated
December 12, 2014
50
ESTIMATED participants
Lead Sponsor
University of Cologne
NCT07264426
NCT06920004
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions